Download Files:
CFT8634
10,285 CAD
Only 1000 item(s) left in stock.
For Research Use Only (RUO). This product is sold strictly for laboratory research use. Not for human or veterinary consumption, therapeutic, or diagnostic use.For sale to research organizations and laboratories only; not for patients or for personal use.
Products Details
Product Description
– CFT8634 is an orally active and selective degrader targeting BRD9, with effects on the proliferation of SMARCB1-deficient cancer cell lines. CFT8634 induces the formation of a ternary complex with BRD9 and E3 ligase, inducing BRD9 ubiquitination and subsequent degradation by the proteasome.
For Research Use Only (RUO). This product is sold strictly for laboratory research use only. Not for human or veterinary consumption, therapeutic, or diagnostic use. Any pharmacological, therapeutic, cosmetic, or biological effects described above are provided as research context only and do not represent intended or approved uses of this product.
Web ID
– T73425
Storage Temperature
– -20℃
Shipping
– Blue Ice
Molecular Formula
– C37H45F3N6O5
References
– Brian A, et al. A Phase 1/2 Study of CFT8634, a Novel Bifunctional Degradation Activating Compound (BIDACmDegrader Of BRD9, in Synovial Sarcoma and SMARCB1-null Tumors.
CAS Number
– 2704617-96-7
Molecular Weight
– C37H45F3N6O5
SMILES
– CC=1C(C2=CC(OC)=C(CN3CC(F)(F)[C@H](CC3)N4CCN(CC4)C5=C(F)C=C(N[C@@H]6C(=O)NC(=O)CC6)C=C5)C(OC)=C2)=CN(C)C(=O)C1C
Pathway
– Chromatin/Epigenetic
Product type
– Small Compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
1000 in stock
Proudly representing
150+ years of combined research-supply heritage
